$AUPH insider trading

Over the last 12 months, Aurinia Pharmaceuticals insiders reported 6 buys totaling $25.1M and 2 sales totaling $546K across SEC Form 4 filings.

$25.1M
$546K
8
2
0%
Side
$100K$1.0MJun '26JulAugSep
TANG KEVIN
Robertson Stephen P.
TANG KEVIN

All insider trades

Scroll the table sideways for price, value and marks.

Sep 10, 2026Robertson Stephen P.▼ Sale11,939$15.95$190K-2%
Aug 21, 2026Robertson Stephen P.▼ Sale20,975$16.97$356K-3.4%
Jun 2, 2026TANG KEVIN▲ Buy206,005$15.28$3.1M+1.6%
Jun 1, 2026TANG KEVIN▲ Buy99$15.34$2K
Jun 1, 2026TANG KEVIN▲ Buy343,521$15.28$5.2M+2.7%
May 29, 2026TANG KEVIN▲ Buy262,682$15.31$4.0M+2.1%
May 29, 2026TANG KEVIN▲ Buy2,299$15.35$35K
Mar 3, 2026TANG KEVIN▲ Buy900,000$14.1$12.7M+7.9%

Every $AUPH filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Aurinia Pharmaceuticals filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AUPH feed.